버텍스

Suzetrigine (Journavx) as Multimodal Therapy for Pain Management in Adults Undergoing Surgery for Hip Fracture

Suzetrigine Added to Multimodal Analgesia for Women Undergoing Minimally Invasive Hysterectomy

A Phase 3b Study of Participant Experience on Povetacicept Administered Via Autoinjector as Compared to Sibeprenlimab Administered Via Prefilled Syringe

Absorption, Distribution, Metabolism, and Excretion of 14C-VX-407 After a Single Oral Dose

Establishing Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1) Extension

Suzetrigine for Postoperative Pain After Total Ankle Replacement

Assessing Suzetrigine for Pain Reduction Following Ureteroscopic Surgery

A Phase 1 Relative Bioavailability Study of a VX-581 Tablet Formulation

Effects of VX-407 on the Pharmacokinetics of Combined Oral Contraceptives

Role of Suzetrigine as a Part of a Multimodal Regimen to Reduce Pain and Opioid Use After Total Knee Arthroplasty

A Phase 1, First-in-human Study of VX-433

A Phase 2 Study to Evaluate Povetacicept in Adults With Generalized Myasthenia Gravis

Evaluation of Pain Treatment After Total Knee Arthroplasty

Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-272 in Healthy Participants

Evaluation of VX-581 in Healthy Participants and in Participants With Cystic Fibrosis

Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy

Phase 2a Study of VX-407 in Participants With ADPKD Who Have a Subset of PKD1 Gene Variants (AGLOW)

Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN)

An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney Transplant

Polycystic Kidney Disease 1 (PKD1) Gene Variant Groups in Autosomal Dominant Polycystic Kidney Disease